Literature DB >> 32647320

Engineered T cells Flt around their targets.

Emma C Morris1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32647320     DOI: 10.1038/s41590-020-0740-3

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  1 in total

1.  Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity.

Authors:  Junyun Lai; Sherly Mardiana; Imran G House; Kevin Sek; Melissa A Henderson; Lauren Giuffrida; Amanda X Y Chen; Kirsten L Todd; Emma V Petley; Jack D Chan; Emma M Carrington; Andrew M Lew; Benjamin J Solomon; Joseph A Trapani; Katherine Kedzierska; Maximilien Evrard; Stephin J Vervoort; Jason Waithman; Phillip K Darcy; Paul A Beavis
Journal:  Nat Immunol       Date:  2020-05-18       Impact factor: 25.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.